Alternate-Day Buprenorphine. Phase V - 6

NCT00000224 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Opioid-Related Disorders

Interventions

DRUG: Buprenorphine

Sponsor

National Institute on Drug Abuse (NIDA)

Collaborators

[object Object]